Skip to main content
. 2024 Aug 2;15:1421520. doi: 10.3389/fimmu.2024.1421520

Figure 3.

Figure 3

Forest plot of progression-free survival (A) and overall survival (B) of immune-targeted therapy with or without transarterial chemo(embolization).